oseltamivir has been researched along with Communicable Diseases, Emerging in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, YL; Pu, DB; Wang, XH; Xia, AM; Yu, H; Zeng, M; Zhu, QR; Zhu, YF | 1 |
| Hay, A; Hungnes, O; Lackenby, A; Lina, B; Meijer, A; Opp, M; Paget, J; Schweiger, B; van-de-Kassteele, J; van-der-Werf, S; Zambon, M | 1 |
| Govorkova, EA; Uyeki, TM; Webster, RG; White, NJ | 1 |
| Alexandrov, BB; Hardman, J; Janies, DA; Studer, J; Treseder, TW; Valson, C; Voronkin, IO | 1 |
| Dembiński, Ł; Jackowska, T; Marczyńska, M; Radzikowski, A; Smalisz-Skrzypczyk, K; Talarek, E | 1 |
| Al'khovskiĭ, SV; Aristova, VA; Bazarova, MV; Burtseva, EI; Chuchalin, AG; Fediakina, IT; Kolobukhina, LV; Malyshev, NA; Maslov, AM; Merkulova, LN; Morozova, TN; Ponomarenko, RA; Prilipov, AG; Proshina, ES; Samokhvalov, EI; Shchelkanov, MIu; Sutochnikova, OA | 1 |
| Imai, Y | 1 |
| Kiefer, B | 1 |
| Nau, JY | 1 |
| Pearson, H | 1 |
| Kashiwagi, S | 1 |
| Sugaya, N | 1 |
4 review(s) available for oseltamivir and Communicable Diseases, Emerging
| Article | Year |
|---|---|
EMERGING PATHOGENS: INFLUENZA - H7N9.
Topics: Animals; Antiviral Agents; Birds; Communicable Diseases, Emerging; Cough; Fever; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza Vaccines; Influenza, Human; Oseltamivir; Poultry; Radiography, Thoracic; Respiratory Distress Syndrome; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
[Pathogenesis of and therapeutic targets for severe respiratory failure mediated by emerging respiratory virus infection].
Topics: Animals; Antiviral Agents; Communicable Diseases, Emerging; Disease Models, Animal; Drug Design; Humans; Influenza A virus; Influenza, Human; Mice; Molecular Targeted Therapy; Oseltamivir; Respiration, Artificial; Respiratory Distress Syndrome; RNA Interference; Severity of Illness Index | 2011 |
[Threat from newly emerging influenza].
Topics: Animals; Antiviral Agents; Birds; Communicable Diseases, Emerging; Disease Outbreaks; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Oseltamivir; Zanamivir | 2007 |
[Countermeasures for newly-emerging influenza].
Topics: Antiviral Agents; Communicable Diseases, Emerging; Disease Outbreaks; Enzyme Inhibitors; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir | 2007 |
9 other study(ies) available for oseltamivir and Communicable Diseases, Emerging
| Article | Year |
|---|---|
[The first confirmed pediatric case with H7N9 avian influenza virus infection in China].
Topics: Animals; Child, Preschool; China; Communicable Diseases, Emerging; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza, Human; Male; Oseltamivir; Poultry; Real-Time Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction | 2013 |
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.
Topics: Antiviral Agents; Communicable Diseases, Emerging; Drug Resistance, Viral; Enzyme Inhibitors; Europe; Genes, Viral; Hemagglutinins, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; Population Surveillance; Seasons | 2009 |
What is the optimal therapy for patients with H5N1 influenza?
Topics: Animals; Antiviral Agents; Communicable Diseases, Emerging; Disease Outbreaks; Dose-Response Relationship, Drug; Drug Resistance, Viral; Drug Therapy, Combination; Humans; Immunotherapy; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Oseltamivir; Practice Guidelines as Topic | 2009 |
Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages.
Topics: Antiviral Agents; Cluster Analysis; Communicable Diseases, Emerging; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neuraminidase; Oseltamivir; Phylogeny | 2010 |
[Clinical course of influenza A(H1N1)v in children treated in Warsaw in season 2009/2010].
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Communicable Diseases, Emerging; Comorbidity; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia; Poland; Retrospective Studies; Seasons; Treatment Outcome; Urban Population | 2010 |
[Etiotropic therapy of influenza: lessons from the last pandemic].
Topics: Antiviral Agents; Communicable Diseases, Emerging; Drug Resistance, Viral; Early Diagnosis; Hemagglutination, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pandemics; Pneumonia, Viral; Prognosis; Severity of Illness Index; Viral Interference; Viral Tropism; Zanamivir | 2011 |
[Awaiting a pandemic].
Topics: Acetamides; Animals; Antiviral Agents; Communicable Diseases, Emerging; Disease Outbreaks; Humans; Influenza A virus; Influenza, Human; Oseltamivir | 2005 |
[Bird flu, this new menace that glides in our skies (4)].
Topics: Acetamides; Antiviral Agents; Communicable Diseases, Emerging; Disease Outbreaks; Humans; Influenza A virus; Influenza, Human; Oseltamivir | 2005 |
Controlling immune response may cut bird flu death rate.
Topics: Antiviral Agents; Communicable Diseases, Emerging; Cytokines; Disease Outbreaks; Humans; Immune System; Influenza A Virus, H5N1 Subtype; Influenza, Human; Oseltamivir; Vietnam | 2006 |